We are pleased to offer our customers in North America complementary products from ReSyn Biosciences and Promise Proteomics through our online store.
ReSyn Biosciences currently offers a portfolio of innovative magnetic microparticle products, MagReSyn®, designed to specifically address the requirements of bioseparation, mass spectrometry and proteomics sample preparation. The products aim to address key limitations in R&D workflows, including reproducibility and low throughput, by developing automated workflows, and enabling clinical mass spectrometry applications.
Promise Proteomics was created in 2010 as a spin-off of CEA Grenoble. This medtech is currently wholly owned by the Aguettant group and is directed by Dr. Eric Rougemond. Its business model is based on a range of services in bioproduction and on the development of products to label and quantify proteins in biological samples. Since 2013, Promise has been a partner in an innovative and ambitious R&D program that has allowed it to develop its technology, on which the diagnostic kits for personalized medical applications are based. Capitalizing on its unique know-how in the production of internal standards for protein assays and its recognized expertise in mass spectrometry-based quantification methods, Promise Proteomics is placing its skills at the service of health care professionals through its mAb-X-mise kits